Literature DB >> 17425682

Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells.

L Wang1, H Qin, B Chen, X Xin, J Li, H Han.   

Abstract

Human cervical carcinoma is one of the most common malignant tumors, but the mechanisms that orchestrate the multiple oncogenic insults required for initiation and progression are not clear. Notch signaling plays a critical role in maintaining the balance between cell proliferation, differentiation, and apoptosis, but perturbed Notch signaling may contribute to tumorigenesis. We now show that Notch1 is detected in all cervical cancer, including advanced diseases. We also constitutively overexpressed active Notch1 in human cervical carcinoma to explore the effects of Notch1 signaling on human cervical carcinoma cell growth and to investigate the underlying molecular mechanisms. The signaling may participate in the development of human cervical carcinoma cells, but overexpressed active Notch1 inhibits their growth through induction of cell cycle arrest. Increased Notch1 signaling induced a downmodulation of human papillomavirus transcription through suppression of activator protein (AP)-1 activity by upregulation of c-Jun and the decreased expression of c-Fos. Thus, Notch1 signaling plays a key role and exerts dual effects, functioning in context-specific manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425682     DOI: 10.1111/j.1525-1438.2007.00927.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  19 in total

1.  NOTCH1 regulates migration and invasion of skin cancer cells by E-cadherin repression.

Authors:  Zhipeng Wang; Linna Liu; Meng Wang; Min Shen; Jing Li; Juanjuan Liu; Chen Li; Chunyan Xin; Shaojun Zhu; Qibing Mei; Yukun Wang
Journal:  Mol Cell Biochem       Date:  2011-10-29       Impact factor: 3.396

2.  Identification of differential expressed transcripts in cervical cancer of Mexican patients.

Authors:  Leticia Santos; Ma Fabiola León-Galván; Erika Nahomy Marino-Marmolejo; Ana Paulina Barba de la Rosa; Antonio De León Rodríguez; Roberto González-Amaro; Ramón Gerardo Guevara-González
Journal:  Tumour Biol       Date:  2011-01-13

3.  Notch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice.

Authors:  Pallavi Garg; Sabrina Jeppsson; Guillaume Dalmasso; Amr M Ghaleb; Beth B McConnell; Vincent W Yang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Gastroenterology       Date:  2011-06-30       Impact factor: 22.682

Review 4.  Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis.

Authors:  Trinath Das; Rong Zhong; Michael T Spiotto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.

Authors:  Laura G Franko-Tobin; L Vienna Mackey; Wei Huang; Xiangwei Song; Baofeng Jin; Jing Luo; Lynsie M Morris; Minqiu Liu; Joseph A Fuselier; David H Coy; Lizi Wu; Lichun Sun
Journal:  Oncologist       Date:  2012-01-30

Review 6.  Notch signalling in solid tumours: a little bit of everything but not all the time.

Authors:  Prathibha Ranganathan; Kelly L Weaver; Anthony J Capobianco
Journal:  Nat Rev Cancer       Date:  2011-04-14       Impact factor: 60.716

Review 7.  Notch signaling proteins: legitimate targets for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

8.  Notch1 expression correlates with tumor differentiation status in ovarian carcinoma.

Authors:  Mingyi Wang; Jian Wang; Lin Wang; Liying Wu; Xiaoyan Xin
Journal:  Med Oncol       Date:  2009-12-11       Impact factor: 3.064

Review 9.  Crosstalk of Notch with p53 and p63 in cancer growth control.

Authors:  G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2009-07-16       Impact factor: 60.716

Review 10.  Notch tumor suppressor function.

Authors:  G P Dotto
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.